CASI Pharmaceuticals (NASDAQ:CASI) Now Covered by StockNews.com : vimarsana.com

StockNews.com started coverage on shares of CASI Pharmaceuticals (NASDAQ:CASI – Free Report) in a report published on Sunday. The brokerage issued a hold rating on the biotechnology company’s stock. Separately, HC Wainwright reaffirmed a buy rating and set a $10.00 price objective on shares of CASI Pharmaceuticals in a research report on Monday, August 14th. […]

Related Keywords

United States , Wellington , New Zealand General , New Zealand , , Pharmaceuticals Inc , Susquehanna International Group , Citigroup Inc , Pharmaceuticals Company Profile , Virtu Financial , Renaissance Technologies , Pharmaceuticals Price Performance , Wellington Shields Co , Pharmaceuticals Daily , Free Report , Get Free Report , International Group , Wellington Shields , Casi Pharmaceuticals , Nasdaq Casi , Casi , Medical , Initiated Coverage , Stocknews Com ,